NASDAQ: SAVA
Cassava Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for SAVA

Based on 2 analysts offering 12 month price targets for Cassava Sciences Inc

Min Forecast
$107.00+4,613.66%
Avg Forecast
$111.50+4,811.89%
Max Forecast
$116.00+5,010.13%

Should I buy or sell SAVA stock?

Based on 2 analysts offering ratings for Cassava Sciences Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SAVA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SAVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SAVA stock forecasts and price targets.

SAVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-26Find Out Why
lockedlocked$00.00+00.00%2024-08-08

1 of 1

Forecast return on equity

Is SAVA forecast to generate an efficient return?

Company
N/A
Industry
238.22%
Market
89.51%

Forecast return on assets

Is SAVA forecast to generate an efficient return on assets?

Company
N/A
Industry
34.69%

SAVA earnings per share forecast

What is SAVA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.62

SAVA revenue forecast

What is SAVA's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.0M

SAVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAVA$2.27$111.50+4,811.89%Buy
ZURA$1.66$14.50+773.49%Strong Buy
VIGL$2.64$19.75+648.11%Strong Buy
RENB$0.70N/AN/A
CLYM$1.68N/AN/A

Cassava Sciences Stock Forecast FAQ

Is Cassava Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SAVA) stock is to Buy SAVA stock.

Out of 2 analysts, 1 (50%) are recommending SAVA as a Strong Buy, 0 (0%) are recommending SAVA as a Buy, 1 (50%) are recommending SAVA as a Hold, 0 (0%) are recommending SAVA as a Sell, and 0 (0%) are recommending SAVA as a Strong Sell.

If you're new to stock investing, here's how to buy Cassava Sciences stock.

What is SAVA's earnings growth forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.57%.

Cassava Sciences's earnings in 2025 is -$17,664,000.

In 2025, SAVA is forecast to generate -$29,828,495 in earnings, with the lowest earnings forecast at -$29,828,495 and the highest earnings forecast at -$29,828,495.

What is SAVA's revenue growth forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.68%.

Cassava Sciences's revenue in 2025 is $0.

In 2025, SAVA is forecast to generate $4,811,047,500 in revenue, with the lowest revenue forecast at $4,811,047,500 and the highest revenue forecast at $4,811,047,500.

What is SAVA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SAVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 34.69%.

What is SAVA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SAVA price target, the average SAVA price target is $111.50, with the highest SAVA stock price forecast at $116.00 and the lowest SAVA stock price forecast at $107.00.

On average, Wall Street analysts predict that Cassava Sciences's share price could reach $111.50 by Nov 26, 2025. The average Cassava Sciences stock price prediction forecasts a potential upside of 4,811.89% from the current SAVA share price of $2.27.

What is SAVA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's current Earnings Per Share (EPS) is -$0.37. In 2025, SAVA's EPS is forecast to hit -$0.62 (min: -$0.62, max: -$0.62).

What is SAVA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SAVA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.